A diagnostic system that detects cancer with a single drop of blood! Analyzing microRNA in exosomes (Information on a new cancer screening).
The "Liquid Biopsy" Ark-Test is a cancer detection system that discovers cancer with just a drop of blood. By analyzing microRNA within exosomes secreted by cancer cells, it detects early-stage cancer types. It contributes to the early detection of cancer and curative treatments. The Ark-Test is the world's first innovative technology, successfully identifying 12 types of cancer! It is a highly sensitive, specific, and accurate test that identifies cancer types with just a small amount of blood. The "Ark-Test" can determine the "type of cancer" with a single drop of blood. It is also effective for early cancer detection and as a cancer marker. Since it requires only a small blood sample, it is a test that does not require anesthesia like a CT scan and places minimal burden on the body. The test results can be reported within 3 to 4 days, providing numerical values and an ABC assessment. This testing service can determine cancer types and is capable of early detection (around stage 1). Please feel free to contact us for inquiries. *Medical Ark Co., Ltd. is an affiliated company of ours.
Inquire About This Product
basic information
For more details, please refer to the related links or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the related links or feel free to contact us.
Detailed information
-
Ark-Test Brochure 1
-
Ark-Test Brochure 2
Company information
Our company is engaged in the manufacturing and wholesale of high-performance masks, wholesale of disinfectants such as weakly acidic hypochlorous acid water, and the manufacturing, import, and wholesale of nutritional supplements. In particular, we employ a unique approach that combines advanced technology with high expertise in our development process, and we have established a production system that includes emergency measures for production.
